Laser Focus World is an industry bedrock—first published in 1965 and still going strong. We publish original articles about cutting-edge advances in lasers, optics, photonics, sensors, and quantum technologies, as well as test and measurement, and the shift currently underway to usher in the photonic integrated circuits, optical interconnects, and copackaged electronics and photonics to deliver the speed and efficiency essential for data centers of the future.

Our 80,000 qualified print subscribers—and 130,000 12-month engaged online audience—trust us to dive in and provide original journalism you won’t find elsewhere covering key emerging areas such as laser-driven inertial confinement fusion, lasers in space, integrated photonics, chipscale lasers, LiDAR, metasurfaces, high-energy laser weaponry, photonic crystals, and quantum computing/sensors/communications. We cover the innovations driving these markets.

Laser Focus World is part of Endeavor Business Media, a division of EndeavorB2B.

Laser Focus World Membership

Never miss any articles, videos, podcasts, or webinars by signing up for membership access to Laser Focus World online. You can manage your preferences all in one place—and provide our editorial team with your valued feedback.

Magazine Subscription

Can you subscribe to receive our print issue for free? Yes, you sure can!

Newsletter Subscription

Laser Focus World newsletter subscription is free to qualified professionals:

The Daily Beam

Showcases the newest content from Laser Focus World, including photonics- and optics-based applications, components, research, and trends. (Daily)

Product Watch

The latest in products within the photonics industry. (9x per year)

Bio & Life Sciences Product Watch

The latest in products within the biophotonics industry. (4x per year)

Laser Processing Product Watch

The latest in products within the laser processing industry. (3x per year)

Get Published!

If you’d like to write an article for us, reach out with a short pitch to Sally Cole Johnson: [email protected]. We love to hear from you.

Photonics Hot List

Laser Focus World produces a video newscast that gives a peek into what’s happening in the world of photonics.

Following the Photons: A Photonics Podcast

Following the Photons: A Photonics Podcast dives deep into the fascinating world of photonics. Our weekly episodes feature interviews and discussions with industry and research experts, providing valuable perspectives on the issues, technologies, and trends shaping the photonics community.

Editorial Advisory Board

  • Professor Andrea M. Armani, University of Southern California
  • Ruti Ben-Shlomi, Ph.D., LightSolver
  • James Butler, Ph.D., Hamamatsu
  • Natalie Fardian-Melamed, Ph.D., Columbia University
  • Justin Sigley, Ph.D., AmeriCOM
  • Professor Birgit Stiller, Max Planck Institute for the Science of Light, and Leibniz University of Hannover
  • Professor Stephen Sweeney, University of Glasgow
  • Mohan Wang, Ph.D., University of Oxford
  • Professor Xuchen Wang, Harbin Engineering University
  • Professor Stefan Witte, Delft University of Technology

YPrime's Latest Research Reveals Significant Impact of eCOA Platform Delays on Clinical Trial Efficiency

MALVERN, Pa., Jan. 30, 2024 (GLOBE NEWSWIRE) -- YPrime, the leading pioneer in clinical trial technology, today released the findings of its research of clinical stakeholders regarding their experiences and sentiments with electronic clinical outcomes assessment (eCOA).

The adoption of eCOA in clinical studies has continued to grow, driven by its numerous benefits, including improved data accuracy, enhanced participant compliance, and streamlined study processes. The report reveals opportunities and sentiments about the clinical landscape, including:

  • Top issues keeping clinical professionals up at night regarding eCOA
    • Timelines/Delays (62%)
    • Data change capabilities (50%)
    • Protocol amendments (41%)
  • Average number of protocol amendments in the last 18 months
    • 1-3 Protocol amendments (52%)
    • 4-6 Protocol amendments (35%)
    • 7+ Protocol amendments (13%)
  • Measurements of success in eCOA endpoint collection
    • Visit compliance status (79%)
    • Diary/scale compliance status (77%)
    • Patient enrollment status (65%)

"As the leading eCOA platform provider committed to exceeding the requirements of patients, clinical sites, and sponsors, we are excited to share the perspectives uncovered by our eCOA research,” said Mike Hughes, YPrime Chief Product Officer. “The findings highlight the industry's focus on operational efficiency, data integrity, and patient engagement. We remain dedicated to proactively evolving our platforms to address the dynamic needs of clinical research today and in the future.”

YPrime's survey of clinical stakeholders delves into their concerns, preferences, and measurements of success in eCOA endpoint collection. Take the first step towards more efficient clinical trials: download eCOA Trends for Today and Tomorrow right now.

About YPrime
At YPrime, we pioneer solutions that streamline the clinical trial journey, increasing certainty from study design to data lock. With a foundation built on decades of industry insight and expertise, we are inspired by the life-altering outcomes unlocked by clinical trials. Our dedication to quality is pivotal in propelling the groundbreaking endeavors of our partners, researchers, and investigators. With a technology platform that enables speed, flexibility, and certainty for large and emerging pharma companies alike, we provide eConsent, IRT, eCOA, and patient engagement solutions that solve for certainty in clinical research. To learn more, email marketing@yprime.com or visit www.yprime.com.

Media Contact
Terry Rehm
YPrime
trehm@yprime


Primary Logo

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.